BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 2837968)

  • 1. Receptor-specific mechanisms for the responses of human leukocytes to leukotrienes.
    Goetzl EJ; Sherman JW; Ratnoff WD; Harvey JP; Eriksson E; Seaman WE; Baud L; Koo CH
    Ann N Y Acad Sci; 1988; 524():345-55. PubMed ID: 2837968
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effects of leukotrienes B4 and C4 on bovine aortic endothelial cell proliferation in vitro.
    Modat G; Muller A; Mary A; Grégoire C; Bonne C
    Prostaglandins; 1987 Apr; 33(4):531-8. PubMed ID: 3037607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of regulation of receptors and signal transduction pathways for the peptidyl leukotrienes.
    Crooke ST; Mong S; Sarau HM; Winkler JD; Vegesna VK
    Ann N Y Acad Sci; 1988; 524():153-61. PubMed ID: 2837951
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of arachidonic acid metabolites in local and systemic inflammatory processes.
    Austen KF
    Drugs; 1987; 33 Suppl 1():10-7. PubMed ID: 3036459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo evidence for the chemotactic activity of cyclooxygenase- and lipoxygenase-dependent compounds using a corneal implantation technique.
    Rochels R; Busse WD
    Ophthalmic Res; 1984; 16(4):194-7. PubMed ID: 6089067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotrienes.
    Hammarström S
    Annu Rev Biochem; 1983; 52():355-77. PubMed ID: 6311078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and hypersensitivity.
    Goetzl EJ
    Int Ophthalmol Clin; 1985; 25(2):25-34. PubMed ID: 2989203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of leukotriene B4-specific chemotactic deactivation of human polymorphonuclear leukocytes.
    Boggs JM; Goetzl EJ
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():399-402. PubMed ID: 1847775
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacology of the leukotrienes].
    Sirois P; Borgeat P
    J Pharmacol; 1984; 15 Suppl 1():53-68. PubMed ID: 6328128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the generation and release of leukotrienes from leukocytes.
    Lewis RA
    Prog Clin Biol Res; 1985; 199():163-72. PubMed ID: 2999819
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular diversity of human leukocyte receptors.
    Koo CH; Sherman JW; Baud L; Goetzl E
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():191-4. PubMed ID: 2546383
    [No Abstract]   [Full Text] [Related]  

  • 12. Biological actions of leukotrienes. State of the art lecture.
    Ford-Hutchinson A; Letts G
    Hypertension; 1986 Jun; 8(6 Pt 2):II44-9. PubMed ID: 3013771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienes.
    Di Gennaro A; Carnini C; Buccellati C; Ballerio R; Zarini S; Fumagalli F; Viappiani S; Librizzi L; Hernandez A; Murphy RC; Constantin G; De Curtis M; Folco G; Sala A
    FASEB J; 2004 May; 18(7):842-4. PubMed ID: 15001558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arachidonic acid metabolism by the 5-lipoxygenase pathway, and the effects of alternative dietary fatty acids.
    Lee TH; Austen KF
    Adv Immunol; 1986; 39():145-75. PubMed ID: 3098061
    [No Abstract]   [Full Text] [Related]  

  • 15. Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products.
    Nagy L; Lee TH; Goetzl EJ; Pickett WC; Kay AB
    Clin Exp Immunol; 1982 Mar; 47(3):541-7. PubMed ID: 6282507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of 5-lipoxygenase metabolism by human neutrophils using a combination of activators.
    Maclouf J; Iliou JP; Del Maschio A
    Prostaglandins Leukot Med; 1986 Aug; 23(2-3):105-8. PubMed ID: 3020579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function.
    Lee TH; Hoover RL; Williams JD; Sperling RI; Ravalese J; Spur BW; Robinson DR; Corey EJ; Lewis RA; Austen KF
    N Engl J Med; 1985 May; 312(19):1217-24. PubMed ID: 2985986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between prostaglandins and leukotrienes.
    Kuehl FA; Dougherty HW; Ham EA
    Biochem Pharmacol; 1984 Jan; 33(1):1-5. PubMed ID: 6322789
    [No Abstract]   [Full Text] [Related]  

  • 19. Leukotriene B4 is an incomplete agonist for the activation of human neutrophils.
    Prescott SM; Zimmerman GA; Seeger AR
    Biochem Biophys Res Commun; 1984 Jul; 122(2):535-41. PubMed ID: 6087805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of complement anaphylatoxins in neutrophil arachidonic acid metabolism.
    Clancy RM; Hugli TE
    Prog Clin Biol Res; 1985; 199():173-84. PubMed ID: 2999821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.